Sermorelin Where to Buy: The Seller We Link Falls Short
Summary: Every vial of sermorelin looks the same in a photograph, so the decision has to be made about the seller. Six criteria, ranked, with the supplier on this page scored against all of them including the one it fails.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
Sermorelin where to buy is usually answered with a list of shop names, which is the least useful possible answer. Every vendor photographs the same white powder in the same glass vial. What differs is the paperwork behind it, and paperwork can be judged by anyone in a couple of minutes with a rule to judge it against.
So this page publishes the rule first, then scores the one supplier it links to, including the criterion that supplier does not meet.
Where readers actually buy it
Ascension Peptides — Sermorelin
Research-grade Sermorelin, assayed by an outside lab and shipped from the US. The code below takes half off the vial.
The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Batch certificate published for the lot
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked September 6, 2026.
Sermorelin where to buy is a harder question than it looks
Normally you can anchor a purchase against an approved product. Here you cannot, and the reason is unusual.
Sermorelin was an approved American medicine. It was marketed as Geref by EMD Serono under NDA 019863 for pituitary diagnostics and NDA 020443 for treatment, the latter approved on 26 September 1997 [1]. Both applications now read Discontinued, and FDA's own record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons [1]. It left the market as a commercial decision. DailyMed carries no current labelling for it, so there is no reference product on a shelf to compare a vial against.
That leaves the certificate as the only document standing between you and a guess, which is why every criterion below is really a question about documents.
The evidence picture points the same way. PubMed returns 332 papers mentioning sermorelin and three carrying the word in the title, and it returns nothing at all for sermorelin paired with anti ageing. ClinicalTrials.gov registers no studies naming the compound, so no supplier can point you at a trial to justify a claim. The literature that does exist sits with the approved indications, paediatric growth hormone deficiency and pituitary function testing, which are not what the current market is selling. When there is no evidence base to argue about and no reference product to compare against, the paperwork is the entire argument.
The six criteria, in the order they should decide
One, a certificate tied to your lot. A batch code on the paperwork that matches the batch code on the vial. Anything else describes different material. This is first because it makes the other five meaningful or meaningless.
Two, identity confirmed rather than asserted. Sermorelin is GHRH(1-29) amide, twenty nine residues, formula C149H246N44O42S, mass 3357.9 g/mol, PubChem CID 16132413 [4]. A certificate that prints the sequence or the mass lets you check the vial holds the compound named on the label rather than something adjacent from the same catalogue.
Three, purity by a named method. HPLC with mass spectrometric detection, a stated percentage, and a peak count. A bare number with no method behind it is a marketing figure.
Four, testing scope for anything reconstituted and injected. Endotoxin and sterility are separate assays from purity, they use separate instruments, and a purity result tells you nothing about either [3]. FDA describes the concern for this class of peptides as a risk for immunogenicity due to the potential for aggregation and peptide related impurities [2], which is a testing question first.
Five, domestic dispatch. Not patriotism. A domestic parcel is fewer days in transit, no customs interception, and a jurisdiction where a refund request means something.
Six, written recourse. A published policy stating what happens if a vial arrives damaged, mislabelled or lot mismatched, with a named contact. Verbal reassurance in a chat widget is not a policy.
Scoring the supplier on this page
| Criterion | What we found | Verdict |
|---|---|---|
| Certificate tied to the lot | One certificate published, MZ Biolabs, lot 38-01260229, analysed 7 February 2026 and signed on 13 February, analyst Ken Pendarvis | Pass, and the lot code is printed rather than implied |
| Identity confirmed | The sequence on the certificate converts to YADAIFTNSYRKVLGQLSARKLLQDIMSR, 29 residues with a C terminal amide, agreeing with PubChem CID 16132413 on formula and mass | Pass, checked independently |
| Purity by named method | 99.79 percent by HPLC-UV-MS across four detected peaks | Pass |
| Quantity independently measured | 11.31 mg reported against a 10 mg label, an overfill of 13.1 percent on this lot | Pass, and better than the label promises |
| Endotoxin and sterility | Neither assay appears on the certificate published for this lot | Fail on the criterion that carries the most weight for injected material |
| Domestic dispatch and recourse | US stock with same day dispatch before 2pm CST, published shipping threshold at $250 | Pass on dispatch, and the recourse policy is the part to read before ordering rather than after |
Five passes and one failure, and the failure is on criterion four, which is the one this page said should decide most. We are not going to score around that. The honest summary is that this supplier documents identity, purity and quantity better than most of its market and documents the injectable question not at all on this lot.
Two things people treat as criteria that are not
Price is not a criterion. In a market with no reference product there is no such thing as a suspiciously cheap vial or a reassuringly expensive one. The full arithmetic, including what the assayed overfill does to the per milligram figure, is on our sermorelin price page, and it should be read after the documents rather than before.
The phrase third party tested is not a criterion either. It is a claim about a document, made in place of the document. The test is whether the certificate is on the page, whether the laboratory is named, and whether the lot code matches. Three things you can see, instead of one thing you have to believe.
Quantity tiers are the third thing to set aside at this stage. Buying three, five or ten vials takes 3, 5 or 10 percent off the list price, which is real money and tells you nothing about the material. Volume discounts are a function of a seller's inventory position, not of its documentation, and they arrive at exactly the moment a buyer is least inclined to reread a certificate.
The seller question and the prescriber question are different questions
There is a second route to this compound that does not involve evaluating a supplier at all. Because sermorelin acetate was a component of an approved drug product, a compounding pharmacy in the United States has a lawful basis to work with it on a prescription, and the compound is absent from the FDA bulk substances list that constrains many of its neighbours [2]. Ibutamoren mesylate sits on that list under both 503A and 503B, and ipamorelin acetate, GHRP-2 and GHRP-6 sit on it too. Sermorelin appears in none of those sections.
That makes the pharmacy column real rather than theoretical here, which is rare. We lay the channels side by side on where to buy sermorelin, and walk the prescriber conversation in detail on how to get a sermorelin prescription. If your intended use is personal rather than laboratory, that route is the one to price out first.
For the field by field reading of an individual listing rather than the framework, see sermorelin for sale.
Common questions about where to buy sermorelin
- Which single criterion matters most when buying sermorelin?
- Whether the certificate is tied to the lot you are shipped. Everything else on the document becomes unverifiable if the batch code does not match, because a certificate for a different lot is a report about somebody else's material.
- Should a missing endotoxin test rule a supplier out entirely?
- It depends on what the material is for. For laboratory use, purity and identity may be the whole question. For anything reconstituted and injected, endotoxin and sterility are the assays that speak to the risk, and a certificate covering purity alone has not addressed them.
- Does sermorelin having been an approved drug make research vials safer?
- No. Geref was manufactured under an approved application to that standard. A research vial sold today is a separate supply chain with separate documentation, and its history as an approved medicine tells you nothing about the powder in front of you.
- Is a US supplier automatically better than an overseas one?
- Not automatically, but domestic dispatch removes customs risk, shortens transit and puts a refund request inside a jurisdiction where it can be pursued. Treat it as a strong tiebreaker rather than proof of quality.
- How do I check the vial holds sermorelin and not another growth hormone peptide?
- Compare the certificate against the published identity. Sermorelin is 29 residues with a C terminal amide, formula C149H246N44O42S, mass 3357.9 g/mol, CID 16132413. Ipamorelin and MK-677 are different molecules with different masses and different receptors, and they are frequently sold from the same catalogue page.
The short version
Sermorelin where to buy resolves into six document questions, and the supplier linked here answers five of them well and one of them not at all. It publishes a lot matched certificate from a named laboratory showing 99.79 percent purity and 11.31 mg against a 10 mg label, and that same certificate carries no endotoxin or sterility result. Behind all of it sits a compound that was approved in 1997 and discontinued for commercial reasons, which is also why a prescription route exists alongside the research one. Decide which of those two purchases you are making before you compare any prices.
References
- FDA, Drugs@FDA, Geref (sermorelin acetate), NDA 020443, EMD Serono, original approval 26 September 1997, marketing status Discontinued
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists
- FDA, Pyrogen and Endotoxins Testing: Questions and Answers
- PubChem, Sermorelin, CID 16132413, C149H246N44O42S, 3357.9 g/mol